Browsing by Subject "Therapy"

Sort by: Order: Results:

Now showing items 1-3 of 3

  • Current perspectives on the interleukin-1 family as targets for inflammatory disease. 

    Walsh, Patrick; Lucitt, Margaret (2019)
    Since the first description of interleukin-1 (IL-1) and the genesis of the field of cytokine biology, the understanding of how IL-1 and related cytokines play central orchestrat- ing roles in the inflammatory response has ...

  • The European Vasculitis Society 2016 Meeting Report 

    LITTLE, MARK; Bajema, Ingeborg M.; Bruijn, Jan A.; Casian, Alina; Cid, Maria C.; Csernok, Elena; van Daalen, Emma; Harper, Lorraine; Hauser, Thomas; Luqmani, Raashid; Mahr, Alfred; Ponte, Cristina; Salama, Alan; Segelmark, Mårten; Suzuki, Kazuo; Sznajd, Jan; Teng, Y.K. Onno; Vaglio, Augusto; Westman, Kerstin; Jayne, David (2017)
    The 2016 European Vasculitis Society (EUVAS) meeting, held in Leiden, the Netherlands, was centered around phenotypic subtyping in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV). There were parallel ...

  • The future of Extracellular Vesicles as Theranostics - an ISEV meeting report 

    O'Driscoll, Lorraine; Soekmadji, Carolina; Li, Bo; Huang, Yiyao; Wang, Haifang; An, Taixue; Liu, Chunchen; Pan, Weilun; Chen, Jing; Cheung, Lesley; Falcon-Perez, Juan Manuel; Gho, Yong Song; Holthofer, Harry B.; Le, Minh T.N.; Marcilla, Antonio; Shekari, Faezeh; Shen, Tang Long; Torrecilhas, Ana Claudia; Yan, Xiaomei; Yang, Fuquan; Yin, Hang; Xiao, Yu; Zhao, Zezhou; Zou, Xue; Wang, Qian; Zheng, Lei (2020)
    The utilization of extracellular vesicles (EVs) in clinical theranostics has rapidly advanced in the past decade. In November 2018, the International Society for Extracellular Vesicles (ISEV) held a workshop on “EVs in ...